Academic Medical Center Leadership on Pharmaceutical Company Boards of Directors

• Autores: Timothy S. Anderson, Shravan Dave, Chester B. Good, Walid F. Gellad
• Localización: JAMA: the journal of the American Medical Association, ISSN 0098-7484, Vol. 311, Nº. 13, 2014, págs. 1353-1355
• Idioma: inglés
• Enlaces
  • Texto Completo Ejemplar
• Resumen

  • Financial relationships between the pharmaceutical industry and physicians have come under increased scrutiny. Less attention has been paid to relationships between industry and the leadership of academic medical centers (AMCs), who wield considerable influence over research, clinical, and educational missions.

    When AMC leaders serve on pharmaceutical company boards, they hold a fiduciary responsibility to shareholders to promote the financial success of the company, which may conflict or compete with institutional oversight responsibilities and individual clinical and research practices.1 The potential conflict between responsibilities of individuals who hold leadership roles in both industry and academia deserves exploration.